KELLEY NELSON: Open Payments
NPI 1881843621 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 48 payments from 10 companies in 2025. Trend: 2023 $22 · 2024 $287 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $183 |
| Incyte Corporation | 15 | $167 |
| ABBVIE INC. | 14 | $158 |
| REVANCE THERAPEUTICS, INC. | 1 | $121 |
| Lilly USA, LLC | 4 | $75 |
| UCB, Inc. | 2 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| GENZYME CORPORATION | 1 | $16 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14 |
Products named: TREMFYA, OPZELURA, DAXXIFY, SKYRIZI, Bimzelx, TALTZ, DUPIXENT, RINVOQ.
Industry payments across NM — which companies pay providers there.
